|
Perspectives
Citations 1-10 of 68 total displayed.
|
Most recent content
(8 Oct 2009):
|
The role of complete response in multiple myeloma
- Jean-Luc Harousseau, Michel Attal, and Herve Avet-Loiseau
Blood 2009; 114: 3139-3146.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Apr 1999):
|
Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment
- Mikkael A. Sekeres and David P. Steensma
Blood 2009; 114: 2575-2580.
[Abstract]
[Full text]
[PDF]
Coagulation and innate immune responses: can we view them separately?
- Mieke Delvaeye and Edward M. Conway
Blood 2009; 114: 2367-2374.
[Abstract]
[Full text]
[PDF]
Do studies in humans better depict Th17 cells?
- Francesco Annunziato and Sergio Romagnani
Blood 2009; 114: 2213-2219.
[Abstract]
[Full text]
[PDF]
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
- Shaji Kumar, Sergio Giralt, Edward A. Stadtmauer, Jean L. Harousseau, Antonio Palumbo, William Bensinger, Raymond L. Comenzo, Suzanne Lentzsch, Nikhil Munshi, Ruben Niesvizky, Jesus San Miguel, Heinz Ludwig, Leif Bergsagel, Joan Blade, Sagar Lonial, Kenneth C. Anderson, Patrizia Tosi, Pieter Sonneveld, Orhan Sezer, David Vesole, Michele Cavo, Hermann Einsele, Paul G. Richardson, Brian G. M. Durie, and S. Vincent Rajkumar, on behalf of the International Myeloma Working Group (IMWG)
Blood 2009; 114: 1729-1735.
[Abstract]
[Full text]
[PDF]
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- James W. Vardiman, Jüergen Thiele, Daniel A. Arber, Richard D. Brunning, Michael J. Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M. Le Beau, Eva Hellström-Lindberg, Ayalew Tefferi, and Clara D. Bloomfield
Blood 2009; 114: 937-951.
[Abstract]
[Full text]
[PDF]
Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
- Tiziano Barbui, Alessandra Carobbio, Alessandro Rambaldi, and Guido Finazzi
Blood 2009; 114: 759-763.
[Abstract]
[Full text]
[PDF]
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference
- Giovanni Barosi, Gunnar Birgegard, Guido Finazzi, Martin Griesshammer, Claire Harrison, Hans Carl Hasselbalch, Jean-Jacques Kiladjian, Eva Lengfelder, Mary Frances McMullin, Francesco Passamonti, John T. Reilly, Alessandro M. Vannucchi, and Tiziano Barbui
Blood 2009; 113: 4829-4833.
[Abstract]
[Full text]
[PDF]
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy
- Robert M. Sharkey, Oliver W. Press, and David M. Goldenberg
Blood 2009; 113: 3891-3895.
[Abstract]
[Full text]
[PDF]
Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
- Eleftherios C. Vamvakas and Morris A. Blajchman
Blood 2009; 113: 3406-3417.
[Abstract]
[Full text]
[PDF]
|
|
